Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Chronic myeloid leukaemia (CML), Hodgkin lymphoma, Leukaemia, Lymphoma, Myelodysplastic syndrome (MDS), Myeloma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at a treatment to help the immune system to start working again after having a stem cell transplant from an unrelated donor. This is an allogeneic stem cell transplant.
It was for people with one of the following cancers:
This trial was open for people to join between 2014 and 2019. The team published the results in 2022.
Recruitment start: 2 July 2014
Recruitment end: 19 July 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Persis Amrolia
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
Last reviewed: 12 Apr 2023
CRUK internal database number: 11201
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
